Literature DB >> 10367788

Platelet function abnormalities in Gaucher disease patients.

S Gillis1, E Hyam, A Abrahamov, D Elstein, A Zimran.   

Abstract

Bleeding manifestations are common in Gaucher disease patients. Although usually attributed to thrombocytopenia, some patients with relatively high platelet counts and normal coagulation tests have hemorrhagic phenomena. To investigate whether perturbed platelet function could explain these bleeding manifestations we performed platelet aggregation tests on 32 type I adult Gaucher patients who were not severely thrombocytopenic (platelet counts >50 x 10(9)/L). Seven patients (22%) had abnormal platelet aggregation. In five, platelet aggregation was markedly reduced in response to collagen and ADP and virtually absent in response to epinephrine, whereas two patients had isolated severely impaired epinephrine-induced aggregation. In one patient platelet aggregation markedly improved following one year of enzyme replacement therapy. Incubating normal platelets with high concentrations of glucocerebroside did not impair their ability to aggregate, suggesting that plasma glucocerebroside does not directly interfere with platelet function. Platelet dysfunction is a hitherto unrecognised, relatively common cause of excessive bleeding in Gaucher patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10367788     DOI: 10.1002/(sici)1096-8652(199906)61:2<103::aid-ajh5>3.0.co;2-v

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  9 in total

Review 1.  Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history.

Authors:  Hagit N Baris; Ian J Cohen; Pramod K Mistry
Journal:  Pediatr Endocrinol Rev       Date:  2014-09

Review 2.  Mandibular and dental manifestations of Gaucher disease.

Authors:  H R Saranjam; E Sidransky; W Z Levine; A Zimran; D Elstein
Journal:  Oral Dis       Date:  2012-01-18       Impact factor: 3.511

3.  Primary bone angiosarcoma in a patient with Gaucher disease.

Authors:  Samo Zver; Matej Bracko; Dusan Andoljsek
Journal:  Int J Hematol       Date:  2010-07-27       Impact factor: 2.490

4.  Echocardiographic Assessment of Left Ventricular Function in Type 1 Gaucher's Disease.

Authors:  Mirta Kozelj; Samo Zver; Vesna Zadnik
Journal:  Adv Hematol       Date:  2010-07-20

5.  Replacement Therapy for Gaucher Disease during Pregnancy: A Case Report.

Authors:  Stefano Raffaele Giannubilo; Angela Pasculli; Elisa Tidu; Andrea Ciavattini
Journal:  J Reprod Infertil       Date:  2015 Jan-Mar

6.  Hemorrhagic aspects of Gaucher disease.

Authors:  Hanna Rosenbaum
Journal:  Rambam Maimonides Med J       Date:  2014-10-29

Review 7.  A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.

Authors:  Jérôme Stirnemann; Nadia Belmatoug; Fabrice Camou; Christine Serratrice; Roseline Froissart; Catherine Caillaud; Thierry Levade; Leonardo Astudillo; Jacques Serratrice; Anaïs Brassier; Christian Rose; Thierry Billette de Villemeur; Marc G Berger
Journal:  Int J Mol Sci       Date:  2017-02-17       Impact factor: 5.923

8.  Recommendations for the management of the haematological and onco-haematological aspects of Gaucher disease.

Authors:  Derralynn Hughes; Maria Domenica Cappellini; Marc Berger; Jan Van Droogenbroeck; Maaike de Fost; Dragana Janic; Theodore Marinakis; Hanna Rosenbaum; Jesús Villarubia; Elena Zhukovskaya; Carla Hollak
Journal:  Br J Haematol       Date:  2007-07-26       Impact factor: 6.998

9.  Protein kinase Cα (PKCα) regulates bone architecture and osteoblast activity.

Authors:  Gabriel L Galea; Lee B Meakin; Christopher M Williams; Sarah L Hulin-Curtis; Lance E Lanyon; Alastair W Poole; Joanna S Price
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.486

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.